Key result
Hyponatremia was an independent predictor of all-cause mortality in patients with chronic heart failure secondary to Chagas cardiomyopathy.
Why the study?
Does hyponatremia predict all-cause mortality in patients with chronic heart failure secondary to Chagas cardiomyopathy?
Cohort (n=246)
No
Does hyponatremia predict all-cause mortality in patients with chronic heart failure secondary to Chagas cardiomyopathy?
Hyponatremia is present in 12% of patients with Chagas cardiomyopathy and serves as an independent predictor of all-cause mortality.
Answers are grounded in this paper and cite their sources.
Hyponatremia may flag higher mortality risk in Chagas HF; leaves open whether correction alters outcomes.
The prevalence, the clinical characteristics and the impact of hyponatremia on the prognosis of patients with chronic heart failure secondary to Chagas cardiomyopathy is unknown. All patients with positive serology for Chagas disease and a left ventricular ejection fraction < 55% on echocardiography routinely followed at the cardiomyopathy service of the university hospital from January, 2000 to December, 2008 were screened. The work-up consisted of anamnesis, physical examination, standard laboratory tests, 12-lead resting ECG, and 2-D echocardiography. Hyponatremia was defined as serum sodium levels < 135 mEq/L. 246 patients were entered in the study; 30 (12%) patients were found to have hyponatremia. A multivariate stepwise logistic regression analysis revealed that the need of inotropic support [hazard ratio (HR) = 2.97; 95% Confidence Interval (CI) 1.24 to 7,18; p = 0.01], left ventricular systolic diameter (HR = 1.05; 95% CI 1.0 to 1.1, p = 0.03), and diastolic blood pressure (HR: 0,96; 95% CI 0,92 to 0,99; p = 0.04) were independent predictors of hyponatremia. A Cox regression analysis showed that the need of inotropic support (HR = 1,84; 95% CI 1,24 to 2,72; p = 0,0002), hyponatremia (HR = 2,05; 95% CI 1,25 to 3,38; p = 0.005), Betablocker therapy (hazard ratio = 0,33; 95% Confidence Interval 0,22 to 0,50; p < 0,0005), and digoxin use (HR = 2,79; 95% CI 1,42 to 5,46; p = 0003) were independent predictors of all-cause mortality. Hyponatremia is an independent predictor of all-cause mortality of patients with chronic heart failure secondary to Chagas cardiomyopathy in the contemporary era of syndrome management. Hyponatremia can be predicted by variables consistent with syndrome severity.
No takes yet. Share an insight, caveat, or question.
Bestetti et al. (2015) conducted a cohort in Chronic heart failure secondary to Chagas cardiomyopathy (n=246). Hyponatremia (serum sodium < 135 mEq/L) was evaluated on All-cause mortality (HR 2.05, 95% CI 1.25-3.38, p=0.005). Hyponatremia was an independent predictor of all-cause mortality in patients with chronic heart failure secondary to Chagas cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: